ADARx Pharmaceuticals Raises $446.3 Million in Upsized US IPO
ADARx Pharmaceuticals successfully completed its initial public offering in the US. Investing.com reported the company raised $446.3 million at $17 per share in an upsized offering. Earlier, Intellectia AI had reported the company's plan to raise $350 million, indicating the offering exceeded initial expectations.
3 articles from 2 outlets covered this story. The underlying claim is sourced from a press release.
What do all outlets agree on?
2 outlets covered “ADARx Pharmaceuticals Raises $446.3 Million in Upsized US IPO”. All of them report the following:
- ADARx Pharmaceuticals conducted an IPO
- The IPO was in the US
Which figures do outlets report differently?
1 figure in this story is reported with conflicting values:
IPO Amount$350 Million (Intellectia AI) vs $446.3 Million (Investing.com)
Which outlets covered this?
All 3 articles found on this story, grouped by the stance of the piece. Every link goes to the original publisher.
pragmatist3